Expanded Access of Occlutech's Atrial Flow Regulator
Conditions Not listed
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorOcclutech International AB
About this trial
Occlutech AFR use allowed per FDA's Expanded Access program.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- Catheter implantation of Occlutech AFR device
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov